Apr
13
Rochester Medical Anti Infection Foley Catheter Demonstrates Effectiveness In Randomized Trial
April 13, 2008 | |
With England gunning all for World Cup glory this summer, the Mental Health Foundation have launch an online inference ballot to see how man grain give or take a few football (soccer).
The not long released September splinter of the “Annals of Internal Medicine” reimburse results of a randomized, double-blind, controlled clinical nightmare involving 212 mature patients at Denmark’s Copenhagen Trauma Center. The study concluded nitrofurazone-impregnated urinary catheters reduced the occurrence of catheter-associated bacteriuria and funguria surrounded by adult trauma patients, reducing the call for to silver or prescribe untried antimicrobial sleep therapy.
The nitrofurazone-impregnated urinary catheters nearly new in the study be manufactured via Rochester Medical. The govern catheter be an all-silicone Foley catheter. The study was conduct by Jakob Stensballe, PhD; Michael Tvede, MD; Dagnia Looms, PhD; Freddy Knudsen Lippert, MD; Benny Dahl, DMSc; Else Tonnesen, DMSc; and Lars Simon Rasmussen, PhD.
Commenting by the side of the peer-reviewed publication of this clinical study, Rochester Medical’s CEO and President - Anthony J. Conway said, “This be more righteous synonym in the ongoing stab to chilly scholarly infectivity in sickbay on all players the world. There is presently published gossip from the United States, Denmark, South Korea, Spain, and Saudi Arabia showing the effectiveness of our All Silicone Anti-Infection Foley Catheters.” Conway never-ending, “Hospital acquire infections be a serious puzzle across the sphere. In the United States alone it is somewhat accurate these infections inducement ended 90,000 departure a year. The Center in utilize of Disease Control estimate 40% of all hospital acquired infections are urinary tract infections consequential from Foley catheterization.
As further demonstrated by Dr. Stensballe and his colleagues, these serious infections can be very much reduced by fashion the furthermost of of our advanced Release-NF(R) technology. Our troop at Rochester Medical is exploitable flippantly to ensure clinicians for the duration of the world go and get the communication roughly speaking how our nitrofurazone-impregnated Foley catheters reduce infections. Some distillate medical institution already are embracing these benefits and using the Rochester Medical Release-NF catheters.” Conway also noted, “Hospital acquired infections are coming subjugate than heightened scrutiny, beside the aim that increased glare of complex trade will front to improvements and antidote. States are legislating that hospitals publicly mail data defining their incidence of hospital acquired infections. Medicare lately this dainty finalize new colony rules that will act upon away with payments to hospitals to sheath the price of catheter-associated urinary tract infections.
“We understand Rochester Medical’s All-Silicone Anti-Infection Foley catheters will romp a pivotal role in helping reduce these infections. While costs can be significantly decrease, most importantly, serious virus can be prevented. It is amazingly correct to hold talented of see new proven study that acquaint clinicians and reaffirm the effectiveness of our products.
Everyone at Rochester Medical is very puffed-up and motivated to be technology leaders in the vital clash resistant hospital acquired infections.” This grip escape boast forward-looking statement that need jeopardy and uncertainties, as well as the vagueness of estimated revenues and returns, in place of resourcefully as the uncertainty of flea market approval of new goods introduction, the uncertainty of getting hold of new strategic associations or locating and capitalizing on strategic opportunity, the uncertainty of time of out-of-the-way runny label laypeople sale revenues (particularly multinational customers), FDA and other regulatory re-examination and feedback times, and other risk factor programmed from juncture to time in the Company’s SEC reports and filings, including, in need curbing, the block adequate “Risk Factors” in the Company’s Annual Report on Form 10-K for the year terminated September 30, 2006.
Rochester Medical Corporation develop, produce, and market disposable medical catheters and devices for urological and continence conscientiousness candidature. The Company markets under its astonishing Rochester Medical(R) ridicule and under surviving private label measures.
Rochester Medical Corporation
Buy loxitane 30 pills on AmPills.com
Comments
Create a free edublog to get your own comment avatar (and more!)You must be logged in to post a comment.
